Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2B0U

The Structure of the Follistatin:Activin Complex

Summary for 2B0U
Entry DOI10.2210/pdb2b0u/pdb
DescriptorInhibin beta A chain, Follistatin, IRIDIUM (III) ION, ... (6 entities in total)
Functional Keywordsactivin, follistatin, tgf-beta, morphogen, inhibin, signaling protein
Biological sourceHomo sapiens (human)
More
Cellular locationSecreted: P08476 P19883
Total number of polymer chains4
Total formula weight90655.58
Authors
Thompson, T.B.,Lerch, T.F.,Cook, R.W.,Woodruff, T.K.,Jardetzky, T.S. (deposition date: 2005-09-14, release date: 2005-10-11, Last modification date: 2024-10-30)
Primary citationThompson, T.B.,Lerch, T.F.,Cook, R.W.,Woodruff, T.K.,Jardetzky, T.S.
The Structure of the Follistatin:Activin Complex Reveals Antagonism of Both Type I and Type II Receptor Binding.
Dev.Cell, 9:535-543, 2005
Cited by
PubMed Abstract: TGF-beta ligands stimulate diverse cellular differentiation and growth responses by signaling through type I and II receptors. Ligand antagonists, such as follistatin, block signaling and are essential regulators of physiological responses. Here we report the structure of activin A, a TGF-beta ligand, bound to the high-affinity antagonist follistatin. Two follistatin molecules encircle activin, neutralizing the ligand by burying one-third of its residues and its receptor binding sites. Previous studies have suggested that type I receptor binding would not be blocked by follistatin, but the crystal structure reveals that the follistatin N-terminal domain has an unexpected fold that mimics a universal type I receptor motif and occupies this receptor binding site. The formation of follistatin:BMP:type I receptor complexes can be explained by the stoichiometric and geometric arrangement of the activin:follistatin complex. The mode of ligand binding by follistatin has important implications for its ability to neutralize homo- and heterodimeric ligands of this growth factor family.
PubMed: 16198295
DOI: 10.1016/j.devcel.2005.09.008
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.8 Å)
Structure validation

237735

数据于2025-06-18公开中

PDB statisticsPDBj update infoContact PDBjnumon